Download het volledig rapport (302 p.) - KCE
Download het volledig rapport (302 p.) - KCE
Download het volledig rapport (302 p.) - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
264 Prenatale zorg <strong>KCE</strong> reports vol. 6A<br />
74. Devroey D, Van Casteren V, Vranckx R. Changing patterns in acute<br />
clinical viral hepatitis encountered by Belgian practitioners.<br />
Eurosurveillance 1997; 2 (7): 51-58.<br />
75. Hutchinson SJ, Goldberg DJ, Cameron SO. Hepatitis C virus among<br />
childbearing women in Scotland: prevalence, deprivation and diagnosis.<br />
Gut 2004; 53: 593-598.<br />
76. Tajiri H, Miyoshi Y, Funada S, et al. Prospective study of mother-to-infant<br />
transmission of hepatitis C virus. Pediatr Infect Dis J 2001; 20: 10-4.<br />
77. Colin C, Lanoir D, Touzet S. Sensitivity and specificity of third-generation<br />
hepatitis C virus antibody detection assays: an analysis of the literature.J<br />
Viral Hepat 2001; 8: 87-95.<br />
78. Defraye A, Sasse A. Epidemiologie van AIDS en HIV-infectie in België.<br />
Jaar<strong>rapport</strong>: toestand op 31 december 2002.<br />
(http://www.iph.fgov.be/epidemio/epinl/aidsnl)<br />
79. Kiss P, Sergooris L, Decrans L. Immuniteit voor rubella bij vrouwen<br />
tussen 20 en 40 jaar tewerkgesteld in kinderdagverblijven en<br />
kleuteronderwijs. Tijdschr voor Geneeskunde 1997; 53(10): 655-662.<br />
80. Vandekerckhove K, Verstraete A, Leroux-Roels G. De immuunstatus<br />
voor rubella en toxoplasmosis bij meisjes van 12 tot 18 jaar. Tijdschr<br />
voor Geneeskunde 1996; 52(5): 319-323.<br />
81. Hoffmann K, Temmerman M. Rubella en zwangerschap. Tijdschr voor<br />
Geneeskunde 1999; 55(5): 340-343.<br />
82. Lumbiganon P, Piaggio G, Villar J, et al. The epidemiology of syphilis in<br />
pregnancy. Int J STD & AIDS 2002; 13: 486-494.<br />
83. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for<br />
preventing congenital toxoplasmosis. Am J Perinatol 1994; 11(1): 57-62.<br />
84. Foulon W, Pinon JM, Stray-Pedersen B, et al. Prenatal diagnosis of<br />
congenital toxoplasmosis: a multicenter evaluation of different diagnostic<br />
parameters. Am J Obstet Gynecol 1999; 181: 843-7.<br />
85. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis<br />
during pregnancy: A multicenter study of impact on fetal transmission<br />
and children´s sequelae at age of 1 year. Am J Obstet Gynecol 1999; 180:<br />
410-5.<br />
86. Pebody RG, Andrews N, Brown D, et al. The sero-epidemiology of<br />
herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect 2004;<br />
80(3): 185-91.<br />
87. Stamilio D, Olsen T, Ratcliffe S, et al. False-positive 1-hour glucose<br />
challenge test and adverse perinatal outcomes. Obstet Gynecol 2004;<br />
103(1): 148-156.<br />
88. Caliskan E, Kayikcioglu F, Öztürk N, et al. A population-based risk factor<br />
scoring will decrease unnecessary testing for the diagnosis of gestational<br />
diabetes mellitus. Acta Obstet Gynecol Scand 2004; 83: 524-530.<br />
89. Lauenborg J, Hansen T, Jensen DM, et al. Increasing incidence of diabetes<br />
after gestational diabetes: a long-term follow-up in a Danisch population.<br />
Diabetes Care 2004; 27(5): 1194-1199.<br />
90. Collaris RJ, OEI SG. External cephalic version: a safe procedure? A<br />
systematic review of version-related risks. Acta Obstet Gynecol Scand<br />
2004; 83: 511-8<br />
91. Belgische Vereniging voor de Strijd tegen Mucoviscidose. Informatie over<br />
mucoviscidose: België in cijfers. (http://www.muco.be)